Using Perfluorooctyl Bromide to Treat Detached Retinas
Perfluorooctyl Bromideessential for Repositioning Giant Retinal Breaks and Can be Used for Removal of Subretinal Fluid as Well as Stabilization of the Retina to Offset
This study tests if a special fluid can help flatten detached retinas and improve vision for patients with serious retinal problems.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 20 (estimated) |
| Ages | 20 Years to 50 Years |
| Sex | All |
| Sponsor | EL Romany Ophthalmics Factory Industry-sponsored |
| Locations | 1 site (Cairo, Kubri EL Kubba) |
| Trial ID | NCT05699096 on ClinicalTrials.gov |
What this trial studies
This observational study investigates the use of perfluorooctyl bromide to flatten detached retinas and displace underlying fluids. It focuses on patients diagnosed with retinal disease, particularly those with giant retinal breaks. The study aims to assess the effectiveness of this intervention in stabilizing the retina and facilitating the removal of subretinal fluid. Participants will be monitored for their visual outcomes and overall retinal health.
Who should consider this trial
Good fit: Ideal candidates are individuals aged 20 years or older diagnosed with keratoconus and without other active ocular diseases.
Not a fit: Patients under 20 years of age or those with severe visual impairment (best corrected visual acuity worse than 20/400) may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve the management of retinal detachments and enhance visual outcomes for patients.
How similar studies have performed: While this approach is innovative, similar studies have shown promise in using perfluorocarbon liquids for retinal surgery, indicating potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * \- Is 20 years or older Has been diagnosed with Keratoconus; Has no other active ocular disease; Is not pregnant or nursing; Exclusion Criteria: * Is under the age of 20 Has best corrected visual acuity outside 20/400; Pregnant or nursing at the time of enrollment in the study;
Where this trial is running
Cairo, Kubri EL Kubba
- Girgis Boules — Cairo, Kubri EL Kubba, Egypt (Recruiting)
Study contacts
- Study coordinator: El R Ophthalmics
- Email: drmina@elromanyophthalmics.com
- Phone: +201212331343
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.